•
RV
RVMD
Revolution Medicines, Inc. Common Stock
yahooBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
22.72B
Volume
3.24M
52W High
$124.49
52W Low
$29.17
Open
$0.00
Prev Close
$116.22
Day Range
0.00 - 0.00
About Revolution Medicines, Inc. Common Stock
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
Latest News
Sandisk, Bloom Energy, And Oklo Are Among the Top 10 Large-Cap Gainers Last Week (Jan. 5-Jan. 9): Are the Others in Your Portfolio?
Benzinga•Jan 11
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight
Benzinga•Jan 9
Why Revolution Medicines Shares Are Sliding After Hours On Wednesday
Benzinga•Jan 8
Revolution Medicines Announces Key Leadership Additions, including Alan Sandler, M.D. as Chief Development Officer
GlobeNewswire Inc.•Sep 29
Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
GlobeNewswire Inc.•Aug 26
Tango (TNGX) Q2 Revenue Drops 52%
The Motley Fool•Aug 6
Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG462 plus Revolution Medicines’ Daraxonrasib or Zoldonrasib in Patients with RAS-Mutant MTAP-deleted Pancreatic or Lung Cancer
GlobeNewswire Inc.•Jun 27
rEvolution Appoints Brian Gabriel as Vice President of Marketing Communications
GlobeNewswire Inc.•May 27